Somatic Hematologic Cancer Taskforce
The Hematologic Cancer Taskforce will undertake systematic curation of gene and/or variants associated with hematological malignancies for evidence of clinical significance using the Clinical Interpretations of Variants in Cancer (CIViC) platform. Our goal is to generate standardized evidence-based recommendations for utilization of genomic data in clinical practice and research.
The Hematologic Cancer Taskforce is currently accepting members to join the team and support its variant curation and interpretation activities.
Working Group Membership
Membership spans many fields, including genetics, medical, academia, and industry.